PEG-L-asparaginase (Federal Research Institute of Pediatric Hematology, Oncology and Immunology)
N/A
Report date: 2022/11/05 17:26:49
Base Information
Drug NamePEG-L-asparaginase (Federal Research Institute of Pediatric Hematology, Oncology and Immunology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesDmitry Rogachev Federal Research And Clinical Centre Of Paediatric Haematology, Oncology And Immunology
China Registration ClassN/A
Develop Information
Active CompaniesDmitry Rogachev Federal Research And Clinical Centre Of Paediatric Haematology, Oncology And Immunology
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A